The global bio-implants market size reached US$ 117.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 189.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.12% during 2023-2028.
Bio-implants are bioengineered products that are utilized to replace, support, enhance or regularize physiological functions. They are made from biosynthetic materials such as collagen and tissue-engineered products like artificial skin or tissues. They are divided into three categories, namely, biological implants that comprise cell therapy, bioartificial organs and tissue engineering; biologized implants which include in-vivo cell lining, technical implants and biohybrid systems; and biofunctionalized implants that include surface-functionalized implants and drug-eluting stents.
Some of the key players being Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, St. Jude Medical Inc., Medtronic Inc., Smith and Nephew, Wright Medical Group, Zimmer Biomet, Dentsply Sirona, Invibio Limited, Straumann, Danaher Corporation, Cardinal Health, Johnson & Johnson, B. Braun Melsungen, LifeNet Health, Inc and Endo International plc.
Request for a sample copy of this research report: https://www.imarcgroup.com/bio-implants-market/requestsample
Global Bio-Implants Market Trends:
Owing to sedentary lifestyles, altering consumption patterns and inadequate nutritional intake among individuals, the prevalence of chronic conditions, such as osteoarthritis, and neuropathic, congenital and cardiovascular diseases, has increased which, in turn, is augmenting the demand for bio-implants worldwide. In addition, the geriatric population represents the biggest end user of bio-implants as elderly individuals are relatively more susceptible to coronary heart diseases, peripheral artery diseases and other age-related conditions. Apart from this, manufacturers are developing innovative prosthetics to reduce production costs and offer customized devices to patients. Further, due to the increasing beauty consciousness, along with the improving success rate of cosmetic surgeries, there has been a rise in the number of individuals seeking bio-implants for enhancing their physical appearance.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=1162&flag=C
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bio-implants market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type of bio-implants, material, origin, mode of administration and end-user.
Breakup by Type of Bio-Implants:
- Cardiovascular Implants
- Dental Implants
- Spinal Bio-implants
- Orthopaedic Implants
- Ophthalmic Implants
Based on the type of bio-implants, the market has been segmented into cardiovascular implants, dental implants, spinal bio-implants, orthopaedic implants, ophthalmic implants and others.
Breakup by Material:
Based on the type of material, the market has been segmented into metallic, ceramic, polymer and biological.
Breakup by Origin:
Based on the origin, the market has been segmented into allograft, autograft, xenograft and synthetic.
Breakup by Mode of Administration:
- Non Surgical
Based on the mode of administration, the market has been segmented into non-surgical and surgical.
Breakup by End-User:
- Ambulatory Surgical Centers
Based on the end-user, the market has been segmented into ambulatory surgical centers, clinics, hospital and others.
Breakup by Region:
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, St. Jude Medical Inc, Medtronic Inc., Smith and Nephew, Wright Medical Group, Zimmer Biomet, Dentsply Sirona, Invibio Limited, Straumann, Danaher Corporation, Cardinal Health, Johnson & Johnson, B. Braun Melsungen, LifeNet Health, Inc and Endo International plc.
Related Reports By IMARC Group
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Follow us on twitter: @imarcglobal